Listed

Rani Therapeutics Holdings, Inc.

RANINasdaqCIK 1856725HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.7m, Q2 FY2026
Operating income−$8.8m, Q2 FY2026
Net income−$7.4m, Q2 FY2026
Rani Therapeutics Holdings, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reported0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure1.0Revenue, Q4 FY2024, three months to 2024-12-31$1.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure0.2Revenue, Q1 FY2025, three months to 2025-03-31$172.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure1.5Revenue, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure1.7Revenue, Q1 FY2026, three months to 2026-03-31$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure1.7Revenue, Q2 FY2026, three months to 2026-06-30$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Research and development$m11.2Research and development, Q3 FY2023, three months to 2023-09-30$11.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure7.6Research and development, Q4 FY2023, three months to 2023-12-31$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047740. Derived: 12-month figure less the 9-month figure.Report this figure7.6Research and development, Q1 FY2024, three months to 2024-03-31$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure6.1Research and development, Q2 FY2024, three months to 2024-06-30$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure6.2Research and development, Q3 FY2024, three months to 2024-09-30$6.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure6.8Research and development, Q4 FY2024, three months to 2024-12-31$6.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure6.6Research and development, Q1 FY2025, three months to 2025-03-31$6.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure5.5Research and development, Q2 FY2025, three months to 2025-06-30$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure3.2Research and development, Q3 FY2025, three months to 2025-09-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure4.9Research and development, Q4 FY2025, three months to 2025-12-31$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure5.2Research and development, Q1 FY2026, three months to 2026-03-31$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure5.0Research and development, Q2 FY2026, three months to 2026-06-30$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Operating income$m(17.9)Operating income, Q3 FY2023, three months to 2023-09-30−$17.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure(13.4)Operating income, Q4 FY2023, three months to 2023-12-31−$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047740. Derived: 12-month figure less the 9-month figure.Report this figure(14.0)Operating income, Q1 FY2024, three months to 2024-03-31−$14.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure(12.5)Operating income, Q2 FY2024, three months to 2024-06-30−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure(11.8)Operating income, Q3 FY2024, three months to 2024-09-30−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure(15.0)Operating income, Q4 FY2024, three months to 2024-12-31−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure(12.0)Operating income, Q1 FY2025, three months to 2025-03-31−$12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(10.5)Operating income, Q2 FY2025, three months to 2025-06-30−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure(7.3)Operating income, Q3 FY2025, three months to 2025-09-30−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure(8.5)Operating income, Q4 FY2025, three months to 2025-12-31−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure(8.3)Operating income, Q1 FY2026, three months to 2026-03-31−$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(8.8)Operating income, Q2 FY2026, three months to 2026-06-30−$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Interest expense$m1.3Interest expense, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure1.3Interest expense, Q4 FY2023, three months to 2023-12-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-31, accession 0000950170-25-047740. Derived: 12-month figure less the 9-month figure.Report this figure1.3Interest expense, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure1.3Interest expense, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure1.3Interest expense, Q3 FY2024, three months to 2024-09-30$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure1.1Interest expense, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure0.9Interest expense, Q1 FY2025, three months to 2025-03-31$943.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure0.9Interest expense, Q2 FY2025, three months to 2025-06-30$877.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure0.7Interest expense, Q3 FY2025, three months to 2025-09-30$725.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure0.3Interest expense, Q4 FY2025, three months to 2025-12-31$347.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2026, three months to 2026-03-31$88.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$8.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0000950170-25-047740. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(9.2)Net income, Q3 FY2023, three months to 2023-09-30−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure(7.1)Net income, Q4 FY2023, three months to 2023-12-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047740. Derived: 12-month figure less the 9-month figure.Report this figure(7.5)Net income, Q1 FY2024, three months to 2024-03-31−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure(6.8)Net income, Q2 FY2024, three months to 2024-06-30−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure(6.8)Net income, Q3 FY2024, three months to 2024-09-30−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure(8.9)Net income, Q4 FY2024, three months to 2024-12-31−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure(7.3)Net income, Q1 FY2025, three months to 2025-03-31−$7.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(6.7)Net income, Q2 FY2025, three months to 2025-06-30−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure(5.4)Net income, Q3 FY2025, three months to 2025-09-30−$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure(10.3)Net income, Q4 FY2025, three months to 2025-12-31−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Net income, Q1 FY2026, three months to 2026-03-31−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(7.4)Net income, Q2 FY2026, three months to 2026-06-30−$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Diluted EPS$ per share(0.36)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure(0.26)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure(0.24)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figurenot reported(0.22)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(0.18)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure(0.12)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(0.04)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Basic EPS$ per share(0.36)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figurenot reported(0.29)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure(0.26)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure(0.24)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figurenot reported(0.22)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(0.18)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure(0.12)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figurenot reported(0.04)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(0.04)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure

Balance sheet

Cash and equivalents$4.9m, Q2 FY2026
Long-term debt$0, FY2025
Shareholders' equity$39.2m, Q2 FY2026
Rani Therapeutics Holdings, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m5.0Cash and equivalents, Q3 FY2023, at 2023-09-30$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure5.9Cash and equivalents, FY2023, at 2023-12-31$5.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0000950170-25-047740.Report this figure6.9Cash and equivalents, Q1 FY2024, at 2024-03-31$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure4.5Cash and equivalents, Q2 FY2024, at 2024-06-30$4.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure4.3Cash and equivalents, Q3 FY2024, at 2024-09-30$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure3.8Cash and equivalents, FY2024, at 2024-12-31$3.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figure10.1Cash and equivalents, Q1 FY2025, at 2025-03-31$10.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure10.2Cash and equivalents, Q2 FY2025, at 2025-06-30$10.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure4.1Cash and equivalents, Q3 FY2025, at 2025-09-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure18.6Cash and equivalents, FY2025, at 2025-12-31$18.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure9.6Cash and equivalents, Q1 FY2026, at 2026-03-31$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure4.9Cash and equivalents, Q2 FY2026, at 2026-06-30$4.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Current assets$m63.2Current assets, Q3 FY2023, at 2023-09-30$63.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure50.8Current assets, FY2023, at 2023-12-31$50.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047740.Report this figure41.4Current assets, Q1 FY2024, at 2024-03-31$41.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-06, accession 0000950170-24-053548.Report this figure32.0Current assets, Q2 FY2024, at 2024-06-30$32.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091793.Report this figure32.4Current assets, Q3 FY2024, at 2024-09-30$32.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure29.7Current assets, FY2024, at 2024-12-31$29.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figure17.8Current assets, Q1 FY2025, at 2025-03-31$17.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure11.1Current assets, Q2 FY2025, at 2025-06-30$11.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure5.0Current assets, Q3 FY2025, at 2025-09-30$5.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure53.3Current assets, FY2025, at 2025-12-31$53.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure47.1Current assets, Q1 FY2026, at 2026-03-31$47.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure56.5Current assets, Q2 FY2026, at 2026-06-30$56.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Total assets$m70.4Total assets, Q3 FY2023, at 2023-09-30$70.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure57.9Total assets, FY2023, at 2023-12-31$57.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0000950170-25-047740.Report this figure53.5Total assets, Q1 FY2024, at 2024-03-31$53.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-06, accession 0000950170-24-053548.Report this figure43.7Total assets, Q2 FY2024, at 2024-06-30$43.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091793.Report this figure43.5Total assets, Q3 FY2024, at 2024-09-30$43.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure36.6Total assets, FY2024, at 2024-12-31$36.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figure24.1Total assets, Q1 FY2025, at 2025-03-31$24.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure16.9Total assets, Q2 FY2025, at 2025-06-30$16.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure10.1Total assets, Q3 FY2025, at 2025-09-30$10.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure58.6Total assets, FY2025, at 2025-12-31$58.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure51.9Total assets, Q1 FY2026, at 2026-03-31$51.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure60.8Total assets, Q2 FY2026, at 2026-06-30$60.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Current liabilities$m7.3Current liabilities, Q3 FY2023, at 2023-09-30$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure8.0Current liabilities, FY2023, at 2023-12-31$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047740.Report this figure13.4Current liabilities, Q1 FY2024, at 2024-03-31$13.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-06, accession 0000950170-24-053548.Report this figure16.6Current liabilities, Q2 FY2024, at 2024-06-30$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091793.Report this figure20.2Current liabilities, Q3 FY2024, at 2024-09-30$20.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure19.9Current liabilities, FY2024, at 2024-12-31$19.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figure20.1Current liabilities, Q1 FY2025, at 2025-03-31$20.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure20.6Current liabilities, Q2 FY2025, at 2025-06-30$20.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure19.1Current liabilities, Q3 FY2025, at 2025-09-30$19.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure12.7Current liabilities, FY2025, at 2025-12-31$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure13.9Current liabilities, Q1 FY2026, at 2026-03-31$13.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure10.6Current liabilities, Q2 FY2026, at 2026-06-30$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Total liabilities$m35.6Total liabilities, Q3 FY2023, at 2023-09-30$35.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure32.5Total liabilities, FY2023, at 2023-12-31$32.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0000950170-25-047740.Report this figure39.0Total liabilities, Q1 FY2024, at 2024-03-31$39.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-06, accession 0000950170-24-053548.Report this figure38.2Total liabilities, Q2 FY2024, at 2024-06-30$38.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091793.Report this figure37.8Total liabilities, Q3 FY2024, at 2024-09-30$37.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure33.1Total liabilities, FY2024, at 2024-12-31$33.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figure29.5Total liabilities, Q1 FY2025, at 2025-03-31$29.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure26.1Total liabilities, Q2 FY2025, at 2025-06-30$26.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure22.1Total liabilities, Q3 FY2025, at 2025-09-30$22.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure17.1Total liabilities, FY2025, at 2025-12-31$17.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure16.3Total liabilities, Q1 FY2026, at 2026-03-31$16.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure12.9Total liabilities, Q2 FY2026, at 2026-06-30$12.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure
Long-term debt$m28.1Long-term debt, Q3 FY2023, at 2023-09-30$28.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure24.5Long-term debt, FY2023, at 2023-12-31$24.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-31, accession 0000950170-25-047740.Report this figure20.9Long-term debt, Q1 FY2024, at 2024-03-31$20.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-06, accession 0000950170-24-053548.Report this figure17.2Long-term debt, Q2 FY2024, at 2024-06-30$17.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091793.Report this figure13.5Long-term debt, Q3 FY2024, at 2024-09-30$13.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure9.6Long-term debt, FY2024, at 2024-12-31$9.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figure5.9Long-term debt, Q1 FY2025, at 2025-03-31$5.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure2.2Long-term debt, Q2 FY2025, at 2025-06-30$2.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure0.0Long-term debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure0.0Long-term debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figurenot reportednot reported
Current portion of debt$m1.2Current portion of debt, Q3 FY2023, at 2023-09-30$1.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure4.9Current portion of debt, FY2023, at 2023-12-31$4.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047740.Report this figure8.6Current portion of debt, Q1 FY2024, at 2024-03-31$8.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-06, accession 0000950170-24-053548.Report this figure12.3Current portion of debt, Q2 FY2024, at 2024-06-30$12.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091793.Report this figure14.8Current portion of debt, Q3 FY2024, at 2024-09-30$14.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure15.0Current portion of debt, FY2024, at 2024-12-31$15.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figure15.0Current portion of debt, Q1 FY2025, at 2025-03-31$15.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure15.0Current portion of debt, Q2 FY2025, at 2025-06-30$15.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure13.5Current portion of debt, Q3 FY2025, at 2025-09-30$13.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figurenot reportednot reported
Shareholders' equity$m17.6Shareholders' equity, Q3 FY2023, at 2023-09-30$17.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure12.9Shareholders' equity, FY2023, at 2023-12-31$12.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-31, accession 0000950170-25-047740.Report this figure7.4Shareholders' equity, Q1 FY2024, at 2024-03-31$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-06, accession 0000950170-24-053548.Report this figure2.8Shareholders' equity, Q2 FY2024, at 2024-06-30$2.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-06, accession 0000950170-24-091793.Report this figure3.1Shareholders' equity, Q3 FY2024, at 2024-09-30$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure2.0Shareholders' equity, FY2024, at 2024-12-31$2.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001193125-26-126417.Report this figure(3.1)Shareholders' equity, Q1 FY2025, at 2025-03-31−$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure(5.6)Shareholders' equity, Q2 FY2025, at 2025-06-30−$5.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure(7.9)Shareholders' equity, Q3 FY2025, at 2025-09-30−$7.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure33.0Shareholders' equity, FY2025, at 2025-12-31$33.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure28.4Shareholders' equity, Q1 FY2026, at 2026-03-31$28.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure39.2Shareholders' equity, Q2 FY2026, at 2026-06-30$39.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure

Cash flow

Operating cash flow−$9.0m, Q2 FY2026
Capital expenditure$32.0k, Q2 FY2026
Rani Therapeutics Holdings, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(14.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-126763. Derived: 9-month figure less the 6-month figure.Report this figure(12.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0000950170-25-047740. Derived: 12-month figure less the 9-month figure.Report this figure(9.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure(9.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105045. Derived: 6-month figure less the 3-month figure.Report this figure(8.4)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$8.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269774. Derived: 9-month figure less the 6-month figure.Report this figure(8.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure(8.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(5.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349245. Derived: 6-month figure less the 3-month figure.Report this figure(5.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269774. Derived: 9-month figure less the 6-month figure.Report this figure0.3Operating cash flow, Q4 FY2025, three months to 2025-12-31$294.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure(6.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure(9.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349245. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$479.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-126763. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$167.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0000950170-25-047740. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$94.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105045. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$125.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269774. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349245. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269774. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001193125-26-126417. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$32.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349245. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)187.17m, Q2 FY2026
Rani Therapeutics Holdings, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares24.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3024,468,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061137.Report this figure25.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3125,240,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-06, accession 0000950170-24-053548.Report this figure25.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3025,345,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091793.Report this figure25.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3025,552,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0000950170-24-126763.Report this figure26.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3126,034,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070382.Report this figure26.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3026,324,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105045.Report this figure28.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3028,836,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure33.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3133,440,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure36.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3036,542,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure46.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3046,444,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269774.Report this figure180Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31179,996,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-226703.Report this figure187Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30187,168,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349245.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.